BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21193243)

  • 1. Antigen carbohydrate 125 in heart failure: not just a surrogate for serosal effusions?
    Núñez J; Miñana G; González M; Garcia-Ramón R; Sanchis J; Bodí V; Núñez E; Chorro FJ; Llàcer A; Miguel A
    Int J Cardiol; 2011 Feb; 146(3):473-4. PubMed ID: 21193243
    [No Abstract]   [Full Text] [Related]  

  • 2. CA125--a test with a change of heart.
    Sikaris KA
    Heart Lung Circ; 2011 Oct; 20(10):634-40. PubMed ID: 20822954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum carbohydrate antigen 125 has prognostic significance in heart failure, but no implications on treatment.
    Beton O; Yucel O
    Int J Cardiol; 2011 Sep; 151(2):241. PubMed ID: 21724271
    [No Abstract]   [Full Text] [Related]  

  • 4. The tumor marker CA-125 and heart failure.
    Miñana G; Palau P; Núñez J; Sanchis J
    Rev Esp Cardiol; 2010 Oct; 63(10):1213-4. PubMed ID: 20875366
    [No Abstract]   [Full Text] [Related]  

  • 5. [Increased carcinoembryonal antigen--a marker not only for ovarian cancer but also for heart failure].
    Dixen U; Hassager C
    Ugeskr Laeger; 2004 Nov; 166(48):4381-2. PubMed ID: 15587635
    [No Abstract]   [Full Text] [Related]  

  • 6. CA-125 and heart failure: Déjà vu continues.
    Topatan B; Basaran A
    Int J Cardiol; 2011 Mar; 147(2):344-5. PubMed ID: 21255852
    [No Abstract]   [Full Text] [Related]  

  • 7. [CA-125 - does this next biomarker have a chance to hope for an expectation of risk stratification in patients with heart failure?].
    Zieliński T
    Kardiol Pol; 2010 Jul; 68(7):779-80. PubMed ID: 20648435
    [No Abstract]   [Full Text] [Related]  

  • 8. CA125 and immunoinflammatory activity in acute heart failure.
    Miñana G; Núñez J; Sanchis J; Bodí V; Núñez E; Llàcer A
    Int J Cardiol; 2010 Dec; 145(3):547-8. PubMed ID: 20483181
    [No Abstract]   [Full Text] [Related]  

  • 9. Antigen carbohydrate 125 in heart failure: a promising clinical tool.
    Núñez J; Miñana G; Núñez E; Sanchis J
    Int J Cardiol; 2011 Aug; 150(3):369-70. PubMed ID: 21636139
    [No Abstract]   [Full Text] [Related]  

  • 10. One biologic marker (carbohydrate antigen-CA 125), two different diseases (ovarian cancer and congestive heart failure): practical implications of monitoring CA 125 serum levels. A case report.
    Faggiano P; D'Aloia A; Bignotti T; Dei Cas L
    Ital Heart J; 2003 Jul; 4(7):497-9. PubMed ID: 14558304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CA-125 and heart failure: déjà vu or "still to be seen".
    Topatan B; Basaran A
    Int J Cardiol; 2010 Dec; 145(3):626-9. PubMed ID: 21035210
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumour markers in chronic heart failure. Review of the literature and clinical implications.
    Faggiano P; D'Aloia A; Antonini-Canterin F; Vizzardi E; Nicolosi GL; Cas LD
    J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):573-9. PubMed ID: 16858234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CA-125 and heart failure.
    Ege MR; Zorlu A; Yılmaz MB
    Int J Cardiol; 2011 Mar; 147(3):453-4. PubMed ID: 21288582
    [No Abstract]   [Full Text] [Related]  

  • 14. CA-125 and heart failure: reiteration and reappraisal.
    Topatan B; Basaran A
    Int J Cardiol; 2011 Nov; 153(1):76-8. PubMed ID: 21917339
    [No Abstract]   [Full Text] [Related]  

  • 15. Heart failure in patients with aortic stenosis: clinical and prognostic significance of carbohydrate antigen 125 and brain natriuretic peptide measurement.
    Antonini-Canterin F; Popescu BA; Popescu AC; Beladan CC; Korcova R; Piazza R; Cappelletti P; Rubin D; Cassin M; Faggiano P; Nicolosi GL
    Int J Cardiol; 2008 Aug; 128(3):406-12. PubMed ID: 17662495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbohydrate antigen-125: additional accuracy in identifying patients at risk of acute heart failure in acute coronary syndrome.
    De Gennaro L; Brunetti ND; Bungaro R; Montrone D; Cuculo A; Pellegrino PL; Correale M; Di Biase M
    Coron Artery Dis; 2009 Jun; 20(4):274-80. PubMed ID: 19440066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CA 125 tumoral marker plasma levels relate to systolic and diastolic ventricular function and to the clinical status of patients with chronic heart failure.
    Vizzardi E; Nodari S; D'Aloia A; Chiari E; Faggiano P; Metra M; Dei Cas L
    Echocardiography; 2008 Oct; 25(9):955-60. PubMed ID: 18771557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of pleural effusion, CA-125 and NT-proBNP in patients with acute decompensated heart failure.
    Davutoglu V; Yildirim C; Kucukaslan H; Yuce M; Sari I; Tarakcioglu M; Akcay M; Cakici M; Ceylan N; Al B
    Kardiol Pol; 2010 Jul; 68(7):771-8. PubMed ID: 20648434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of CA125 in advanced heart failure patients.
    Monteiro S; Franco F; Costa S; Monteiro P; Vieira H; Coelho L; Oliveira L; Providência LA
    Int J Cardiol; 2010 Apr; 140(1):115-8. PubMed ID: 19285353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of CA 125 concentration in patients with congestive heart failure.
    Skórzyńska H; Solski J; Gernand W; Matras P; Gniwek M; Sokół M
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):261-4. PubMed ID: 16145993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.